Skip to content
TNT-OAC Feasibility Survey
1.
Name & Role
2.
Investigator Site
3.
Email address
4.
Would you be interested in taking part in the TNT-OAC trial?
Yes
No
5.
What perioperative oncological therapy do you routinely offer patients with oesophageal or junctional (Siewert I & II) adenocarcinoma?
Perioperative FLOT
Preoperative CROSS
Other (please specify)
6.
Approximately how many patients are there discussed at your MDT with operable disease per annum?
7.
Of those, how many do you think will be eligible for screening for the trial per annum?
8.
Do you see any issues with obtaining translational samples as detailed (in email/synopsis)?
Yes
No
Maybe (please specify)
9.
Do you have any questions or comments about the trial design?
